Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yina Diao
CONTACT
Lead
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
This is a randomized, open-label, multicenter Phase 3 clinical study to evaluate SKB264 monotherapy versus Treatment of Physician's Choice (TPC) in subjects with unresectable locally advanced, recurrent, or metastatic HR+/HER2- breast cancer who had failed at least one line of systemic chemotherapy.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted